Sarah S. Darwish

First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents

Mostafa M. Hamed, Sarah S. Darwish, Jennifer Herrmann et al. · Journal of Medicinal Chemistry · 2017 · 31 citations · Full text

Medicine, Oncology, Pharmacology +14

Development of novel 2,4-bispyridyl thiophene–based compounds as highly potent and selective Dyrk1A inhibitors. Part I: Benzamide and benzylamide derivatives

Sarah S. Darwish, Mohammad Abdel‐Halim, Mohamed Salah et al. · European Journal of Medicinal Chemistry · 2018 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Psychosocial factors correlate with fatigue among pregnant women in Jordan

Dalal Yehia, Malakeh Z. Malak, Nancy N. Al‐Thwabih et al. · Perspectives In Psychiatric Care · 2019 · 24 citations

Public Health, Maternal Health, Obstetrics +15

Development of novel amide–derivatized 2,4-bispyridyl thiophenes as highly potent and selective Dyrk1A inhibitors. Part II: Identification of the cyclopropylamide moiety as a key modification

Sarah S. Darwish, Mohammad Abdel‐Halim, Ahmed K. ElHady et al. · European Journal of Medicinal Chemistry · 2018 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity

Omar M. Al-Saad, Moustafa T. Gabr, Sarah S. Darwish et al. · European Journal of Medicinal Chemistry · 2024 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17